AOTI, Inc., together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, a negative pressure disposable wound therapy system for use in home, acute and extended care settings. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.…
REG - AOTI, Inc. - Holding(s) in Company
AOTI (LON: AOTI) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 90 employees.
The shares were at 145.00 GBp on 20 November 2026, up 286.7% over 52 weeks. Its 52-week range is 25.00 GBp to 150.00 GBp: the price is 3.3% below the high and 480.0% above the low.
At a market capitalisation of 153.85M GBP, it trades at 72.5 times trailing earnings and 51.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, a premium of 184% for AOTI.
AOTI reports return on equity of 17.4%, an operating margin of 8.7% and revenue up 10.8% year over year.
Its debt exceeds its cash by 7.36M USD, a debt-to-equity ratio of 0.51. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 176.50 GBp is 21.7% above the current price.
No upcoming events tracked.